loader
Please Wait
Applying Filters...

Approved Drug Products containing NCGC00024890-10 listed in the FDA Orange Book. Original Data : FDA Website

Menu
$ API Ref.Price (USD/KG) : 5,607Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1ACCORD HLTHCARE

02 1ACTAVIS LABS FL INC

03 1ALKEM LABS LTD

04 1AUROBINDO PHARMA

05 1HIKMA

06 1MERZ PHARMS GMBH

07 1MICRO LABS

08 1RISING

09 1SUN PHARM

10 1TEVA PHARMS USA INC

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Boulder Peptide 2024
Not Confirmed
arrow
arrow
Boulder Peptide 2024
Not Confirmed

DALFAMPRIDINE

Brand Name : DALFAMPRIDINE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 10MG

Approval Date : 2018-07-11

Application Number : 206863

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

blank

02

Boulder Peptide 2024
Not Confirmed
arrow
arrow
Boulder Peptide 2024
Not Confirmed

DALFAMPRIDINE

Brand Name : DALFAMPRIDINE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 10MG

Approval Date : 2017-01-23

Application Number : 206836

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

blank

03

Boulder Peptide 2024
Not Confirmed
arrow
arrow
Boulder Peptide 2024
Not Confirmed

DALFAMPRIDINE

Brand Name : DALFAMPRIDINE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 10MG

Approval Date : 2018-07-30

Application Number : 206765

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

blank

04

Boulder Peptide 2024
Not Confirmed
arrow
arrow
Boulder Peptide 2024
Not Confirmed

DALFAMPRIDINE

Brand Name : DALFAMPRIDINE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 10MG

Approval Date : 2017-01-23

Application Number : 206811

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

blank

05

Boulder Peptide 2024
Not Confirmed
arrow
arrow
Boulder Peptide 2024
Not Confirmed

DALFAMPRIDINE

Brand Name : DALFAMPRIDINE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 10MG

Approval Date : 2018-10-24

Application Number : 206646

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

blank

06

Boulder Peptide 2024
Not Confirmed
arrow
arrow
Boulder Peptide 2024
Not Confirmed

DALFAMPRIDINE

Brand Name : DALFAMPRIDINE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 10MG

Approval Date : 2019-03-11

Application Number : 210158

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

blank

07

Boulder Peptide 2024
Not Confirmed
arrow
arrow
Boulder Peptide 2024
Not Confirmed

DALFAMPRIDINE

Brand Name : DALFAMPRIDINE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 10MG

Approval Date : 2020-07-06

Application Number : 206858

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

blank

08

Boulder Peptide 2024
Not Confirmed
arrow
arrow
Boulder Peptide 2024
Not Confirmed

DALFAMPRIDINE

Brand Name : DALFAMPRIDINE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 10MG

Approval Date : 2019-05-21

Application Number : 208292

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

blank

09

Boulder Peptide 2024
Not Confirmed
arrow
arrow
Boulder Peptide 2024
Not Confirmed

DALFAMPRIDINE

Brand Name : DALFAMPRIDINE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 10MG

Approval Date :

Application Number : 206854

RX/OTC/DISCN :

RLD :

TE Code :

blank

10

MERZ PHARMS GMBH

Country
Boulder Peptide 2024
Not Confirmed
arrow

MERZ PHARMS GMBH

Country
arrow
Boulder Peptide 2024
Not Confirmed

DALFAMPRIDINE

Brand Name : AMPYRA

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 10MG

Approval Date : 2010-01-22

Application Number : 22250

RX/OTC/DISCN : RX

RLD : Yes

TE Code : AB

blank